Pure Global
NCT06409793

Motivating Adolescent Fitness

University of British Columbia·ClinicalTrials.gov·behavioralNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Exercise Training
Drug/Device/Intervention
mHealth
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
University of British Columbia
Location
Kelowna, Canada
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2024
End date
Aug 31, 2025
Enrollment
120 participants
Primary outcome

Eligibility to participate in the intervention,Enrolment in the intervention

Summary

The researchers are investigating whether adding mobile technology to a home-based exercise
 counselling program makes it easier for youth to begin and maintain regular exercise.
 Participants who joins the study will receive exercise counselling from an exercise
 specialist, but half of all participants will receive mobile technology - a fitness watch -
 that links to a mobile phone App. The mobile App allows the exercise specialist to provide
 personalized feedback throughout the program via the fitness watch. The investigators are
 interested to know whether the fitness watch and mobile App will make it easier for youth to
 achieve their exercise goals. Both groups will be compared to an active control group, who
 will receive no exercise program.

ICD-10 classifications
Orthoptic trainingLack of physical exerciseOther physical therapyCardiac rehabilitationExhaustion due to excessive exertion
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06409793
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06409793 through Pure Global AI's free database. This phase not specified trial is sponsored by University of British Columbia and is currently Not yet recruiting. The study focuses on Exercise Training. Target enrollment is 120 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.